Evidence map›Paper›PMID 26629129›Full record

ArticleInternational journal of clinical and experimental medicine2015

Performance evaluation of FlowCytomix assays to quantify cytokines in patients with rheumatoid arthritis.

Xuefeng Wang, Liyang Dong, Yong Liang, Hongchang Ni, Jun Tang, Chengcheng Xu, Yuepeng Zhou, Yuting Su, Jun Wang, Deyu Chen and 1 more

Abstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Immunomodulatory effect ofThe journal of venomous animals and toxins including tropical diseases · 2024
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Xuefeng WangDepartment of Nuclear Medicine, The Affiliated Hospital of Jiangsu University Zhenjiang 212001, P. R. China ; Institute of Oncology, The Affiliated Hospital of Jiangsu University Zhenjiang 212001, P. R. China ; Department of Rheumatology, The Affiliated People's Hospital, Jiangsu University Zhenjiang 212002, Jiangsu, P. R. China.
Liyang DongDepartment of Nuclear Medicine, The Affiliated Hospital of Jiangsu University Zhenjiang 212001, P. R. China ; Institute of Oncology, The Affiliated Hospital of Jiangsu University Zhenjiang 212001, P. R. China.
Yong LiangClinical Laboratory, Huai'an Hospital Affiliated of Xuzhou Medical College Huaian, P. R. China.
Hongchang NiDepartment of Rheumatology, The Affiliated People's Hospital, Jiangsu University Zhenjiang 212002, Jiangsu, P. R. China.
Jun TangDepartment of Rheumatology, The Affiliated People's Hospital, Jiangsu University Zhenjiang 212002, Jiangsu, P. R. China.
Chengcheng XuDepartment of Nuclear Medicine, The Affiliated Hospital of Jiangsu University Zhenjiang 212001, P. R. China ; Institute of Oncology, The Affiliated Hospital of Jiangsu University Zhenjiang 212001, P. R. China.
Yuepeng ZhouDepartment of Nuclear Medicine, The Affiliated Hospital of Jiangsu University Zhenjiang 212001, P. R. China ; Institute of Oncology, The Affiliated Hospital of Jiangsu University Zhenjiang 212001, P. R. China.
Yuting SuDepartment of Nuclear Medicine, The Affiliated Hospital of Jiangsu University Zhenjiang 212001, P. R. China ; Institute of Oncology, The Affiliated Hospital of Jiangsu University Zhenjiang 212001, P. R. China.
Jun WangDepartment of Rheumatology, The Affiliated People's Hospital, Jiangsu University Zhenjiang 212002, Jiangsu, P. R. China.
Deyu ChenDepartment of Nuclear Medicine, The Affiliated Hospital of Jiangsu University Zhenjiang 212001, P. R. China ; Institute of Oncology, The Affiliated Hospital of Jiangsu University Zhenjiang 212001, P. R. China.
Chaoming MaoDepartment of Nuclear Medicine, The Affiliated Hospital of Jiangsu University Zhenjiang 212001, P. R. China ; Institute of Oncology, The Affiliated Hospital of Jiangsu University Zhenjiang 212001, P. R. China.
Jiangsu University · CNXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo compare the cytokine profile in RA patients and healthy control by using two methods-FlowCytomix assay and traditional ELISA.

methodsCytokine levels were evaluated by FlowCytomix assay and ELISA in serum and supernatants of peripheral blood mononuclear cells (PBMC) cultures with and without stimulation by phytohaemagglutinin (PHA).

resultsThe levels of IL-6, IL-1β, and TNF-α were significantly higher in sera of RA patients than those of healthy controls. The levels of IL-22, IL-6, IL-1β, TNF-α, and IL-10 were higher in unstimulated PBMC culture supernatant of RA patients than those of healthy controls. PHA stimulation significantly increased the production of proinflammatory cytokines from PBMC with RA patients. Compared with detectable cytokine levels in sera, cytokine concentration in the supernatant of PBMCs was remarkably higher. FlowCytomix and ELISA showed significant correlation in detecting cytokines. However, the FlowCytomix assay detected more cytokines than ELISA.

conclusionThe supernatant of PBMCs provide a fine condition for the study of cytokine production because of the lack of interference factors in sera. The FlowCytomix assay is more sensitive than ELISA in detecting cytokines from RA patients. Multiple cytokine signatures using FlowCytomix assay may represent a more realistic approach in the future of personalized medicine in RA.

Indexed as

Cytokine profileELISAFlowCytomix assayrheumatoid arthritis

Identifiers

PMID26629129
PMCPMC4659018
OpenAlexW2193298394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.